PL4082524T3 - Preparaty triazynowe - Google Patents

Preparaty triazynowe

Info

Publication number
PL4082524T3
PL4082524T3 PL21200376.8T PL21200376T PL4082524T3 PL 4082524 T3 PL4082524 T3 PL 4082524T3 PL 21200376 T PL21200376 T PL 21200376T PL 4082524 T3 PL4082524 T3 PL 4082524T3
Authority
PL
Poland
Prior art keywords
triazine
formulations
triazine formulations
Prior art date
Application number
PL21200376.8T
Other languages
English (en)
Inventor
Anne Claire Le Meur
Florence Guimberteau
Original Assignee
CEVA Santé Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47471627&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL4082524(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by CEVA Santé Animale SA filed Critical CEVA Santé Animale SA
Publication of PL4082524T3 publication Critical patent/PL4082524T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D99/00—Subject matter not provided for in other groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Paints Or Removers (AREA)
PL21200376.8T 2012-12-07 2013-12-06 Preparaty triazynowe PL4082524T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12306548.4A EP2740492A1 (en) 2012-12-07 2012-12-07 Triazine formulations with a second active ingredient and surfactant(s)

Publications (1)

Publication Number Publication Date
PL4082524T3 true PL4082524T3 (pl) 2025-06-23

Family

ID=47471627

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21200376.8T PL4082524T3 (pl) 2012-12-07 2013-12-06 Preparaty triazynowe

Country Status (22)

Country Link
US (4) US11331321B2 (pl)
EP (3) EP2740492A1 (pl)
JP (2) JP6363092B2 (pl)
KR (1) KR102242359B1 (pl)
CN (3) CN105007944A (pl)
AU (1) AU2013353984B2 (pl)
BR (1) BR112015013179B1 (pl)
CA (1) CA2892888C (pl)
CL (1) CL2015001565A1 (pl)
DK (1) DK4082524T3 (pl)
ES (1) ES3030283T3 (pl)
FI (1) FI4082524T3 (pl)
HR (2) HRP20220341T1 (pl)
HU (2) HUE071706T2 (pl)
MX (1) MX374912B (pl)
PH (1) PH12015501219A1 (pl)
PL (1) PL4082524T3 (pl)
PT (2) PT4082524T (pl)
RU (1) RU2652136C2 (pl)
SI (2) SI4082524T1 (pl)
UA (1) UA115460C2 (pl)
WO (1) WO2014086960A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP3473268A1 (en) * 2017-10-20 2019-04-24 IDT Biologika GmbH Combined preparation for parenteral use
KR102920596B1 (ko) * 2018-05-16 2026-01-30 세바 상뜨 아니말르 수의학적 조성물 및 이의 비-인간 포유동물에서 철 결핍을 조절하기 위한 용도
EP3578182A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 (en) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
DE102018220624A1 (de) 2018-11-29 2020-06-04 B. Braun Melsungen Ag Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden
KR102797828B1 (ko) * 2019-04-12 2025-04-22 현대자동차주식회사 사이드링크 통신을 수행하는 방법 및 그 장치

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145142A (en) 1962-05-31 1964-08-18 Du Pont Anticonvulsant process and composition
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
US4493826A (en) * 1982-01-25 1985-01-15 Schering Corporation Gentamicin-gleptoferron compositions
DE3300793A1 (de) 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
US5219853A (en) 1983-01-12 1993-06-15 Bayer Aktiengesellschaft Agent for coccidiosis
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
DE19603984A1 (de) 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
DE19603954C2 (de) 1996-02-05 2003-04-17 Wagon Automotive Gmbh Prallträger für ein Kraftfahrzeug
US6470017B1 (en) 1998-04-21 2002-10-22 Nippon Telegraph And Telephone Corporation Packet multiplexing apparatus
DE19824483A1 (de) 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
WO2000019964A2 (en) 1998-10-08 2000-04-13 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
WO2001026660A1 (en) 1999-10-08 2001-04-19 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10111053A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Wirkstoffkombinationen aus alpha-Liponsäure und Biochinonen
DE10356869A1 (de) * 2003-12-03 2005-07-07 Beiersdorf Ag Tensidhaltige Zubereitung mit Licochalcon A
WO2005091853A2 (en) * 2004-02-27 2005-10-06 Centocor, Inc. Methods and compositions for treating il-13 related pathologies
EP1819383A4 (en) 2004-12-01 2010-08-18 Acushot Inc INJECTOR WITHOUT NEEDLE
ES2812250T3 (es) * 2005-11-28 2021-03-16 Marinus Pharmaceuticals Inc Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
WO2007134642A1 (en) * 2006-05-24 2007-11-29 Universität Hannover Laser device comprising a diffraction grating and coupled laser resonators
US8123718B2 (en) 2006-06-07 2012-02-28 Acushot Inc. Charging mechanism for a needle free injector
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
KR20080035374A (ko) * 2006-10-19 2008-04-23 주식회사 엘지생명과학 약제학적으로 안정한 메게스트롤 물질의 현탁액제
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
FR2917381B1 (fr) 2007-06-15 2009-10-16 Ceva Sante Animale Sa Conditionnement plastique multicouche pour la conservation d'une composition pharmaceutique
TW201006515A (en) 2008-03-07 2010-02-16 Pharmajet Inc Intradermal injector and uses thereof
SI22751A (sl) 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
CN102316856A (zh) * 2009-02-27 2012-01-11 韩兀生物制药株式会社 药物制剂
CN101904858A (zh) * 2009-06-04 2010-12-08 天津瑞普生物技术股份有限公司 一种抗球虫混悬剂的制备方法
US7655597B1 (en) * 2009-08-03 2010-02-02 Specialty Fertilizer Products, Llc Pesticide compositions including polymeric adjuvants
CN102000100A (zh) * 2009-09-01 2011-04-06 天津瑞普生物技术股份有限公司 一种抗球虫的纳米混悬剂及其配制方法
CN102144975B (zh) * 2010-12-24 2012-12-12 山东省医药工业研究所 头孢丙烯混悬药物组合物
CN102743334A (zh) * 2012-07-30 2012-10-24 郑州后羿制药有限公司 一种妥曲珠利注射剂及其制备方法
EP2740469A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale New treatments with triazines
EP2740470A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Treatment of Coccidiosis with intramuscular triazine composition
EP2740492A1 (en) 2012-12-07 2014-06-11 Ceva Sante Animale Triazine formulations with a second active ingredient and surfactant(s)

Also Published As

Publication number Publication date
CL2015001565A1 (es) 2015-10-23
US20150313940A1 (en) 2015-11-05
WO2014086960A1 (en) 2014-06-12
US11331321B2 (en) 2022-05-17
US20220023304A1 (en) 2022-01-27
HUE071706T2 (hu) 2025-09-28
KR20150107734A (ko) 2015-09-23
ES3030283T3 (en) 2025-06-27
PH12015501219B1 (en) 2015-08-17
EP4082524B1 (en) 2025-02-26
BR112015013179B1 (pt) 2021-10-26
JP6363092B2 (ja) 2018-07-25
FI4082524T3 (fi) 2025-05-23
CN111494387A (zh) 2020-08-07
HRP20250623T1 (hr) 2025-07-18
AU2013353984B2 (en) 2017-12-21
CN105007944A (zh) 2015-10-28
EP4082524A1 (en) 2022-11-02
MX374912B (es) 2025-03-06
EP2740492A1 (en) 2014-06-11
MX2015007130A (es) 2015-10-20
BR112015013179A2 (pt) 2017-07-11
KR102242359B1 (ko) 2021-04-20
AU2013353984A1 (en) 2015-06-11
US20220265665A1 (en) 2022-08-25
CA2892888A1 (en) 2014-06-12
US11903946B2 (en) 2024-02-20
CN110201175A (zh) 2019-09-06
JP2018138569A (ja) 2018-09-06
HUE057711T2 (hu) 2022-05-28
CA2892888C (en) 2019-03-12
EP2928498B1 (en) 2021-11-10
HRP20220341T1 (hr) 2022-05-13
SI4082524T1 (sl) 2025-07-31
PT2928498T (pt) 2022-03-08
EP2928498A1 (en) 2015-10-14
RU2015127020A (ru) 2017-01-13
US11903947B2 (en) 2024-02-20
UA115460C2 (uk) 2017-11-10
US11911391B2 (en) 2024-02-27
SI2928498T1 (sl) 2022-05-31
JP2016505558A (ja) 2016-02-25
US20220023305A1 (en) 2022-01-27
PT4082524T (pt) 2025-05-29
PH12015501219A1 (en) 2015-08-17
DK4082524T3 (da) 2025-05-26
RU2652136C2 (ru) 2018-04-25

Similar Documents

Publication Publication Date Title
ZA201407694B (en) Substituted pyrrolidine-2-carboxamides
EP2934531A4 (en) COMBINATION
SG11201404344XA (en) Substituted pyrrolidine-2-carboxamides
GB201420527D0 (en) Electrical-wire-protecting member
EP2911673A4 (en) COMBINATION
SI4082524T1 (sl) Formulacije s triazinom
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
GB2501004B (en) Two piece drysuit
GB2518076B (en) Electrical-wire-protecting member
IL234747A0 (en) Vascular formulations
GB201210530D0 (en) Extended release formulations
GB201209739D0 (en) Aerobars
EP2925728A4 (en) COMBINATION
GB201206178D0 (en) Formulations
EP2908816A4 (en) ASSOCIATION
EP2908815A4 (en) COMBINATION
GB201216178D0 (en) Combination
GB201215711D0 (en) Higher
GB201223361D0 (en) Combines
GB201223358D0 (en) Combines
GB201214705D0 (en) Wee-slip
GB201210260D0 (en) GeoReach
GB201210102D0 (en) finallythebestpantsever
GB201209372D0 (en) Corcost-98963569
GB201209378D0 (en) Corcost-55660022